Prevention of recurrence of hepatocellular carcinoma with anti-viral therapy for hepatitis C virus
Aikata, H.; Chayama, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 73 Suppl. 9: 311-315
2015
ISSN/ISBN: 0047-1852 PMID: 26845951 Document Number: 681412
Document emailed within 1 workday
Related Documents
Tarao, K.; Ohkawa, S.; Tamai, S.; Shimizu, A. 1995: Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 740-745Jiang, M.D. 1993: Serum anti-hepatitis C virus and hepatitis C virus RNA in patients with hepatocellular carcinoma Zhonghua Yi Xue Za Zhi 73(3): 131-134; 189
Uchiyama, K.; Ueno, M.; Hama, T.; Kawai, M.; Tani, M.; Terasawa, H.; Ozawa, S.; Uemura, R.; Nakase, T.; Yamaue, H. 2005: Recurrence of primary hepatocellular carcinoma after hepatectomy--differences related to underlying hepatitis virus species Hepato-Gastroenterology 52(62): 591-595
Koyama, H.; Nishizawa, Y.; Kinoshita, H.; Fujimoto, T.; Morii, H. 1988: Hepatocellular carcinoma with occult chronic hepatitis--hepatitis B virus as a pathogenetic factor of hepatocellular carcinoma Osaka City Medical Journal 34(1): 51-66
Watanabe, H.; Ueno, Y. 2015: Seroclearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in hepatitis B virus patients during nucleoside/nucleotide analog therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 459-465
Ueda, T.; Chung, H.; Kudo, M. 2011: Effects of interferon treatment on recurrence and survival after curative treatment of hepatitis C virus-related hepatocellular carcinoma Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 4): 319-324
Komorizono, Y.; Sako, K.; Yamasaki, N.; Hiwaki, T.; Sakurai, K.; Shibatou, T.; Maeda, M.; Kohara, K.; Shigenobu, S.; Hasegawa, S.; Arima, T.; Oketani, M.; Ishibashi, K.; Arima, T. 2002: Outcome of patients with hepatitis C virus-related hepatocellular carcinoma occurring after interferon therapy Anticancer Research 22(6b): 3573-3578
Korba, B.E.; Cote, P.J.; Menne, S.; Toshkov, I.; Baldwin, B.H.; Wells, F.V.; Tennant, B.C.; Gerin, J.L. 2004: Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection Antiviral Therapy 9(6): 937-952
Chiba, T.; Matsuzaki, Y.; Abei, M.; Shoda, J.; Tanaka, N.; Osuga, T.; Aikawa, T. 1996: The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma American Journal of Gastroenterology 91(6): 1195-1203
Sarr, A.; Sow, A.M.; Diallo, A.; Mendez, V.; Ka Cisse, M. 1996: Comparison of hepatitis B virus and hepatitis C virus seroprevalence in hepatocellular carcinoma Dakar Medical Spec No: 21-23
Simmons, G.C.; Yeong, M.L.; Lee, S.P. 1983: The association of hepatitis B viral infection and hepatocellular carcinoma in New Zealand New Zealand Medical Journal 96(739): 669-671
Leone, N.; Rizzetto, M. 2005: Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma Minerva Gastroenterologica E Dietologica 51(1): 31-46
Shapiro, I.I.; Shabrov, A.V.; Karev, V.E.; Leenman, E.E.; Kvetnoĭ, I.M.; Tsinzerling, V.A.; Sologub, T.V. 2005: Clinical and molecular correlation between chronic hepatitis and hepatocellular carcinoma induced by hepatitis B virus Arkhiv Patologii 67(2): 6-10
Tu, H.; Gao, H.-f.; Ma, G.-h.; Liu, Y. 2006: Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B Zhonghua Yi Xue Za Zhi 86(18): 1249-1252
Huang, M.J.; Liaw, Y.F. 1990: Thyroxine-binding globulin in patients with chronic hepatitis B virus infection: different implications in hepatitis and hepatocellular carcinoma American Journal of Gastroenterology 85(3): 281-284
Li, R-cheng.; Yang, J-ye.; Gong, J.; Li, Y-ping.; Huang, Z-neng.; Fang, K-xiong.; Xu, Z-yi.; Liu, C-bai.; Zhao, K.; Zhuang, H. 2004: Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma Zhonghua Liu Xing Bing Xue Za Zhi 25(5): 385-387
Khin, L.W.; Teo, C.J.; Guan, R. 1996: Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore Singapore Medical Journal 37(5): 492-496
Kotoh, K.; Sakai, H.; Morotomi, I.; Nawata, H. 1995: The use of percutaneous ethanol injection therapy for recurrence of hepatocellular carcinoma Hepato-Gastroenterology 42(3): 197-200
Shuqun, C.; Mengchao, W.; Han, C.; Feng, S.; Jiahe, Y.; Wenming, C.; Peiun, W.; Yuxiang, Z. 2004: Combination transcatheter hepatic arterial chemoembolization with thymosin alpha1 on recurrence prevention of hepatocellular carcinoma Hepato-Gastroenterology 51(59): 1445-1447
Brechot, C.; Wain-Hobson, S.; Pourcel, C.; Dejean, A.; Hadchouel, M.; Scotto, J.; Tiollais, P. 1983: Hepatitis B virus DNA and human hepatocellular carcinoma Progress in Clinical and Biological Research 132d: 495-504